PolyPid Competitors and Similar CompaniesClear all
Adaptimmune's competitors and similar companies include VBI Vaccines.
 Adaptimmune Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. |  VBI Vaccines VBI Vaccines is a biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology. | |
Founding Date | Founding Date 2008 | Founding Date 2001 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Philadelphia, US HQ Milton, GB Milton, GB Stevenage, GB | Locations Cambridge, US HQ Ottawa, CA Rehovot, IL |
Employees | Employees 4007% decrease | Employees 12314% increase |
Valuation ($) | Valuation ($) 188.5 m | Valuation ($) 1.9 m |
Financial | ||
Revenue (est.) | Revenue (est.) $178m (FY, 2024) | Revenue (est.) $8.7m (FY, 2023) |
Net income | Net income ($70.8m) (FY, 2024) | Net income ($92.8m) (FY, 2023) |
For sources of this data, please see the company profile
View Company Profiles
VBI Vaccines
HQ
Cambridge, US
Employees
123↑ 14% increase
VBI Vaccines is a biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology.
View company